Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5822.67 | 21 / 21 | 100% | 159.90 | 504 / 504 |
esophagus | 100% | 6205.64 | 1445 / 1445 | 100% | 131.80 | 183 / 183 |
uterus | 100% | 6084.59 | 170 / 170 | 100% | 181.37 | 459 / 459 |
lung | 100% | 5094.83 | 578 / 578 | 100% | 137.03 | 1154 / 1155 |
thymus | 100% | 7463.48 | 653 / 653 | 100% | 171.93 | 604 / 605 |
intestine | 100% | 8163.05 | 966 / 966 | 100% | 188.54 | 526 / 527 |
prostate | 100% | 6616.11 | 245 / 245 | 100% | 170.57 | 501 / 502 |
ovary | 100% | 6671.56 | 180 / 180 | 100% | 97.19 | 429 / 430 |
stomach | 100% | 5530.95 | 359 / 359 | 100% | 163.33 | 285 / 286 |
skin | 100% | 4665.24 | 1809 / 1809 | 100% | 106.10 | 470 / 472 |
breast | 100% | 4587.25 | 459 / 459 | 99% | 116.04 | 1111 / 1118 |
pancreas | 100% | 2867.89 | 327 / 328 | 99% | 138.55 | 177 / 178 |
liver | 100% | 2886.45 | 226 / 226 | 95% | 59.36 | 386 / 406 |
kidney | 100% | 4766.22 | 89 / 89 | 95% | 64.89 | 856 / 901 |
adrenal gland | 100% | 5311.16 | 258 / 258 | 82% | 47.91 | 188 / 230 |
brain | 81% | 1441.86 | 2150 / 2642 | 83% | 46.68 | 582 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 221.53 | 29 / 29 |
spleen | 100% | 8382.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 188.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.93 | 1 / 1 |
blood vessel | 100% | 4129.28 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3561.93 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6354.36 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 2242.23 | 844 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 60.24 | 76 / 80 |
muscle | 69% | 835.96 | 552 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0042475 | Biological process | odontogenesis of dentin-containing tooth |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_1902455 | Biological process | negative regulation of stem cell population maintenance |
GO_0060789 | Biological process | hair follicle placode formation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0021766 | Biological process | hippocampus development |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_2000736 | Biological process | regulation of stem cell differentiation |
GO_2000273 | Biological process | positive regulation of signaling receptor activity |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0043922 | Biological process | negative regulation by host of viral transcription |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006346 | Biological process | DNA methylation-dependent heterochromatin formation |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0006476 | Biological process | protein deacetylation |
GO_0061198 | Biological process | fungiform papilla formation |
GO_0009913 | Biological process | epidermal cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0031507 | Biological process | heterochromatin formation |
GO_0030182 | Biological process | neuron differentiation |
GO_0042659 | Biological process | regulation of cell fate specification |
GO_0010832 | Biological process | negative regulation of myotube differentiation |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0007492 | Biological process | endoderm development |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0048714 | Biological process | positive regulation of oligodendrocyte differentiation |
GO_0060766 | Biological process | negative regulation of androgen receptor signaling pathway |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_2001243 | Biological process | negative regulation of intrinsic apoptotic signaling pathway |
GO_0061029 | Biological process | eyelid development in camera-type eye |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0043124 | Biological process | negative regulation of canonical NF-kappaB signal transduction |
GO_0036120 | Biological process | cellular response to platelet-derived growth factor stimulus |
GO_0000792 | Cellular component | heterochromatin |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0070822 | Cellular component | Sin3-type complex |
GO_0043025 | Cellular component | neuronal cell body |
GO_0017053 | Cellular component | transcription repressor complex |
GO_0000118 | Cellular component | histone deacetylase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0016581 | Cellular component | NuRD complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0033558 | Molecular function | protein lysine deacetylase activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0001046 | Molecular function | core promoter sequence-specific DNA binding |
GO_0004407 | Molecular function | histone deacetylase activity |
GO_0031492 | Molecular function | nucleosomal DNA binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0001222 | Molecular function | transcription corepressor binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0035851 | Molecular function | Krueppel-associated box domain binding |
GO_0002039 | Molecular function | p53 binding |
GO_0070888 | Molecular function | E-box binding |
GO_0160009 | Molecular function | histone decrotonylase activity |
GO_0005515 | Molecular function | protein binding |
GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
GO_0051059 | Molecular function | NF-kappaB binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | HDAC1 |
Protein name | Histone deacetylase 1 (HD1) (EC 3.5.1.98) (Protein deacetylase HDAC1) (EC 3.5.1.-) (Protein decrotonylase HDAC1) (EC 3.5.1.-) Histone deacetylase 1 Histone deacetylase (EC 3.5.1.98) Histone deacetylase 1 (EC 3.5.1.98) (Protein deacetylase HDAC1) (Protein decrotonylase HDAC1) |
Synonyms | RPD3L1 hCG_41610 |
Description | FUNCTION: Histone deacetylase that catalyzes the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) . Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events . Histone deacetylases act via the formation of large multiprotein complexes . Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin . As part of the SIN3B complex is recruited downstream of the constitutively active genes transcriptional start sites through interaction with histones and mitigates histone acetylation and RNA polymerase II progression within transcribed regions contributing to the regulation of transcription . Also functions as a deacetylase for non-histone targets, such as NR1D2, RELA, SP1, SP3, STAT3 and TSHZ3 . Deacetylates SP proteins, SP1 and SP3, and regulates their function . Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons . Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation . Deacetylates TSHZ3 and regulates its transcriptional repressor activity . Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B . Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity . Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development (By similarity). Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-BMAL1 heterodimer (By similarity). Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation (By similarity). In addition to protein deacetylase activity, also has protein-lysine deacylase activity: acts as a protein decrotonylase by mediating decrotonylation ((2E)-butenoyl) of histones . . |
Accessions | B5MGH2 Q6IT96 B5BU61 Q5TEE2 Q13547 ENST00000373548.8 ENST00000428704.1 |